Development of Anti-Asthma Drugs

Development of Anti-Asthma Drugs

1st Edition - October 2, 1984

Write a review

  • Authors: Derek R. Buckle, Harry Smith
  • eBook ISBN: 9781483192475

Purchase options

Purchase options
DRM-free (PDF)
Sales tax will be calculated at check-out

Institutional Subscription

Free Global Shipping
No minimum order


Development of Anti-Asthma Drugs reviews existing asthma treatments and novel approaches currently under investigation, in the context of their mode of action and clinical effectiveness, in the hope that this might lead to a greater understanding of the factors involved in the expression of the disease and, therefore, in the design of better drugs. It is planned based on the concept of the causes and treatment of asthma, This book is organized in three main parts. Part I deals with the nature of asthma, its pathological mechanisms, natural history and epidemiology. Part II discusses mediators associated with asthma including platelet-activating factor, leukotrienes and histamine. Part II covers pharmaceutical approaches in the development of anti-asthma drugs and includes sections on inhibitors of mediator release and competitive and functional antagonists. This book will be of interest to persons dealing with studies on anti-asthma drugs and those interested in pharmacological development.

Table of Contents

  • Contents


    Part 1 Asthma—The Nature of the Disease

    1 Asthma—The Nature of the Disease

    Definition—What Is Asthma?

    Natural History


    Pathological Mechanisms

    Part 2 Mediators

    2 Histamine


    Histamine Release

    Actions of Histamine

    Concluding Remarks

    3 Leukotrienes


    Structure, Formation and Metabolism

    Biological Activities of the Leukotrienes


    4 Platelet-Activating Factor


    Historical Overview of Platelet-Activating Factor

    Structure and Metabolism of PAF

    PAF Production In Inflammation

    PAF-Induced Platelet Stimulation

    Other Inflammatory Effects of PAF


    Effects On Smooth Muscle

    Effects of Vascular Permeability

    Pharmacological Modulation


    5 Eosinophils and Neutrophils


    General Properties of Eosinophils and Neutrophils

    Allergy and the Eosinophil

    Allergy and the Neutrophil

    Inflammatory Cells and the Progression of Asthma

    Corticosteroids, Eosinophils and Neutrophils


    6 Acetylcholine Laurie


    Acetylcholine As A Neurotransmitter

    The Cholinergic Nervous System In Asthma


    Part 3 Pharmacological Approaches

    Section 1 Competitive Antagonists

    7 Hi Antihistamines

    8 SRS-A Antagonists

    9 Anti-Cholinergic Drugs

    Section 2 Functional Antagonists

    10 Drugs Acting At Adrenoceptors

    11 Theophylline

    12 Prostaglandins and Related Compounds

    Section 3 Inhibitors of Mediator Release

    13 Disodium Cromoglycate and Compounds With Similar Activities

    14 Corticosteroids

    15 Non-Steroidal Inhibitors of Arachidonic Acid Metabolism

    16 Specific Hyposensitization



Product details

  • No. of pages: 416
  • Language: English
  • Copyright: © Butterworth-Heinemann 1984
  • Published: October 2, 1984
  • Imprint: Butterworth-Heinemann
  • eBook ISBN: 9781483192475

About the Authors

Derek R. Buckle

Harry Smith

Affiliations and Expertise

Paediatric Haematologist, Department of Pathology, Royal Brisbane hospital; Clinical Professor in Child Health, University of Queensland

Ratings and Reviews

Write a review

There are currently no reviews for "Development of Anti-Asthma Drugs"